Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Drug-free nanoparticle scavenges cell-free DNA and ROS to treat inflammatory bowel disease

Feb. 7, 2022

PLA2-IIA modulates immunity through its interaction with microbiota

Feb. 3, 2022

New murine model of AIH developed using a human liver protein

Feb. 2, 2022

New ENPP2 inhibitors identified at Suzhou Ark Biopharmaceutical

Feb. 1, 2022

Chengdu Fanxi Biopharma identifies PPAR-alpha and/or PPAR-delta agonists

Jan. 31, 2022

Zealand Pharma divulges LPAM-1 antagonists

Jan. 27, 2022

PL-8177 shows promise in preclinical models of induced colitis

Jan. 25, 2022

Shanghai Institute of Materia Medica identifies new S1PR1 agonists

Jan. 24, 2022

Kallyope presents new AMPK activators

Jan. 20, 2022

HGF mimetic CM-1021 stimulates liver growth in mice

Jan. 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...